Quick Answer
IOVANCE BIOTHERAPEUTICS, INC. reported Stockholders Equity of $698.58 million for fiscal year 2025.
IOVANCE BIOTHERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $698.58M | -1.7% |
| 2024 | $710.40M | +21.5% |
| 2023 | $584.61M | +17.0% |
| 2022 | $499.64M | -19.6% |
| 2021 | $621.66M | -5.3% |
| 2020 | $656.50M | +119.6% |
| 2019 | $298.97M | -35.9% |
| 2018 | $466.19M | +220.4% |
| 2017 | $145.48M | -12.8% |
| 2016 | $166.92M | +60.5% |
| 2015 | $104.02M | +132.0% |
| 2014 | $44.84M | +154.8% |
| 2013 | $17.60M | +255.5% |
| 2012 | -$11.32M | +11.4% |
| 2011 | -$12.78M | -2103.0% |
| 2010 | $638.1K | +4830.8% |
| 2009 | -$13.5K | -690.5% |
| 2008 | $2.3K | -96.3% |
| 2007 | $61.0K | +662.5% |
| 2007 | $8.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $702.29M | -9.2% | +0.5% |
| June 30, 2025 | $698.49M | -9.1% | -9.0% |
| March 31, 2025 | $767.87M | +12.9% | +8.1% |
| December 31, 2024 | $710.40M | +21.5% | -8.2% |
| September 30, 2024 | $773.46M | +14.8% | +0.6% |
| June 30, 2024 | $768.54M | +32.8% | +13.0% |
| March 31, 2024 | $680.02M | +2.0% | +16.3% |
| December 31, 2023 | $584.61M | +17.0% | -13.3% |
- IOVANCE BIOTHERAPEUTICS, INC. showed a decrease of -1.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, IOVANCE BIOTHERAPEUTICS, INC.’s stockholders equity has grown by 8732187.5% (from $8.0 thousand to $698.58 million).
- The most recent figure is from IOVANCE BIOTHERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: